FDA Adverse Event Malfunction Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 3982225 · Received August 5, 2014

Report

Report Number
3004209178-2014-90145
Event Type
Malfunction
Date Received
August 5, 2014
Date of Event
July 3, 2014
Report Date
July 5, 2014
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
OYC
PMA / PMN Number
P980022
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX
Reporter Occupation
PATIENT FAMILY MEMBER OR FRIEND

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. THE DEVICE HAS BEEN RETURNED, BUT NOT YET EVALUATED. FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME.

Additional Manufacturer Narrative · 1

A COMPLETE ANALYSIS AND TESTING OF THE INSULIN PUMP SHOWED THAT IT WAS FUNCTIONING PROPERLY AND PASSED ALL FUNCTIONAL TESTING. AFTER TESTING, IT WAS CONCLUDED THAT THE DEVICE OPERATED WITHIN SPECIFICATIONS.

Description of Event or Problem · 1

CUSTOMER'S MOTHER CALLED STATING HER DAUGHTER'S INSULIN PUMP HAS BEEN ALARMING WEAK BATTERY SINCE LAST THURSDAY. CUSTOMER CHANGES THE BATTERY AND THE DEVICE TURNS ON, SHOWING AN ANTENNA ICON, BUT THEN TURNS OFF. CUSTOMER SAID THE DEVICE IS ON NOW AND GOES THROUGH CYCLES. CUSTOMER'S BLOOD GLUCOSE IS 56 MG/DL. SHE TREATED WITH BREAKFAST. CUSTOMER WAS ADVISED THE DEVICE WILL STILL FUNCTION, BUT THE BATTERY LIFE WILL BE SHORTER THAN USUAL. CUSTOMER USES ENERGIZER BATTERIES. THE BATTERY WAS NOT PREVIOUSLY USED. THE DEVICE WAS NOT BUMPED OR DROPPED. THE BATTERY CAP IS NOT LOOSE OR DAMAGED. CUSTOMER WAS ADVISED THE DEVICE NEEDS TO BE REPLACED, AND TO DISCONTINUE USE AND REVERT TO A BACK UP PLAN. NOTHING FURTHER REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
457358 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-523NAS

Patients

Seq Age Sex Outcome Treatment
1 17 YR